⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1
globenewswire.com
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
Form 8-K
sec.gov
BBIO
Form 8-K
sec.gov
BBIO
BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates
globenewswire.com
BBIO
BridgeBio to Participate in May and June Investor Conferences
globenewswire.com
BBIO
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
globenewswire.com
BBIO
Condor Software Launches Advanced Analytics and Dynamic Scenario Suite
prnewswire.com
ACAD
BBIO
MDGL
BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE
globenewswire.com
BBIO
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
globenewswire.com
BBIO